GlaxoSmithKline Pharmaceuticals Ltd
GlaxoSmithKline Pharmaceuticals Energy Data Preview
In 2024, GlaxoSmithKline Pharmaceuticals disclosed key data related to its energy management practices, providing transparency into its operational energy use in line with recognized sustainability reporting frameworks.
GlaxoSmithKline Pharmaceuticals disclosed progress toward renewable energy adoption, highlighting the share of total energy sourced from renewable versus non-renewable sources.
However, GlaxoSmithKline Pharmaceuticals did not provide a breakdown of its energy sources or generation technologies, limiting visibility into its energy mix and the role of renewables versus fossil fuels.
| Metric (GJ) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Energy Consumed | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Renewable Energy Consumed | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Non-renewable Energy Consumed | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Electricity Consumed | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected energy data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into GlaxoSmithKline Pharmaceuticals's Energy Renewability
In 2024, GlaxoSmithKline Pharmaceuticals consumed a total of 112,564 Gigajoules of energy across its operations. Of this total, 47.42% was sourced from renewable energy, either derived from natural resources like biofuels, biomass, or biogas, or generated using renewable technologies such as solar or wind power. The remaining 52.58% was classified as non-renewable energy, coming from fossil-based fuels such as coal, natural gas, or crude oil, or from non-renewable generation technologies like nuclear power.
GlaxoSmithKline Pharmaceuticals's Energy Renewability Rate
How much of GlaxoSmithKline Pharmaceuticals's energy consumed is renewable?
In 2024, GlaxoSmithKline Pharmaceuticals consumed a total of 112,564 Gigajoules of energy, of which 47.42% was derived from renewable sources, including biofuels, biomass, biogas, solar, and wind power.
This moderate level of renewable energy adoption indicates that GlaxoSmithKline Pharmaceuticals is transitioning toward cleaner energy sources, though a significant share of its energy mix still relies on non-renewable inputs.
Are GlaxoSmithKline Pharmaceuticals's energy practices becoming more sustainable?
Since 2024, GlaxoSmithKline Pharmaceuticals's total energy consumption increased by 3.8%, reflecting a recent rise in overall energy demand.
Over the same period, the share of renewable energy in GlaxoSmithKline Pharmaceuticals's consumption increased by 3.3%, showing a recent positive trend in clean energy adoption.
GlaxoSmithKline Pharmaceuticals's Renewable vs Non-renewable Energy Over Time
- Renewable Energy Consumed
- Non-renewable Energy Consumed